Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I

被引:21
|
作者
Olivier, A
Lucie, K
Jean-François, R
Christian-Jacques, L
Paule, S
机构
[1] Inst Biol Mol & Ingn Genet, IBMIG, F-86022 Poitiers, France
[2] UFR Pharm, F-51096 Reims, France
关键词
p14(ARF); topoisomerase I; protein interactions; cell cycle;
D O I
10.1038/sj.onc.1206214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported an interaction between the p14(ARF). protein and human topoisomerase I (Topo 1) resulting in the stimulation of the relaxation activity of Topo 1. Our data showed that the complex between the two proteins was located within the nucleolus. In the present work, we have investigated the regions of p14(ARF). involved in this interaction by using targeted point mutagenesis and deletion mutants. A region encompassing exon 2-encoded sequence was required for physical binding of p14(ARF) to Topo I as well as for stimulatory activity of the enzyme. Exon 1beta-encoded segment was not implicated in the interaction. Moreover, among p14(ARF) point mutants selected for their high conservation among different mammalian species, mutant p14(ARF) (RR87, 88AA) did not stimulate Topo I in spite of its association with the enzyme, suggesting its direct implication in the functional activity of ARE In contrast, one mutant,p14(ARF) (R71A), was more efficient than wild-type protein to activate Topo 1, suggesting that this residue is a key element to modulate Topo I activity. Finally, only ARF-Topo I complexes containing p14(ARF) exon 2 segment were found to be localized in the nucleolus, suggesting that this sulmuclear location is linked to the biological function of the ARF-Topo I complex.
引用
收藏
页码:1945 / 1954
页数:10
相关论文
共 50 条
  • [31] IN VITRO AND IN VIVO ANALYSES OF THE INTERACTION BETWEEN 5.8S RRNA AND ARF PROTEIN REVEAL A NEW DIFFERENCE BETWEEN MURINE P19ARF AND HUMAN P14ARF
    Andrique, Laetitia
    Ayrault, Olivier
    Larsen, Chritian-Jacques
    Seite, Paule
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3424 - 3424
  • [32] In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF
    Andrique, T
    Ayrault, O
    Larsen, CJ
    Séité, P
    ONCOGENE, 2005, 24 (15) : 2580 - 2584
  • [33] In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF
    Laëtitia Andrique
    Olivier Ayrault
    Christian-Jacques Larsen
    Paule Séité
    Oncogene, 2005, 24 : 2580 - 2584
  • [34] The p14ARF Alternate Reading Frame Protein Enhances DNA Binding of Topoisomerase I by Interacting with the Serine 506-Phosphorylated Core Domain
    Bandyopadhyay, Keya
    Li, Pingchuan
    Gjerset, Ruth A.
    PLOS ONE, 2013, 8 (03):
  • [35] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    LABORATORY INVESTIGATION, 2001, 81 (01) : 212A - 212A
  • [36] Inactivation of p14ARF and p53 are inversely correlated in human cell lines.
    Nicholson, SA
    Khan, MA
    Welsh, JA
    McMenamin, MG
    Travis, WD
    Harris, CC
    MODERN PATHOLOGY, 2001, 14 (01) : 212A - 212A
  • [37] NOVEL FUNCTION OF P14ARF IN HUMAN GLIOMAGENESIS: REGULATION OF TFPI AND GLIOMA MEDIATED COAGULATION
    Zerrouqi, Abdessamad
    Pyrzynska, Beata
    Van Meir, Erwin
    NEURO-ONCOLOGY, 2010, 12 : 23 - 23
  • [38] Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas
    Martin Labuhn
    Graham Jones
    Ernst JM Speel
    Daniel Maier
    Christian Zweifel
    Otmar Gratzl
    Erwin G Van Meir
    Monika E Hegi
    Adrian Merlo
    Oncogene, 2001, 20 : 1103 - 1109
  • [39] TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation
    A Pollice
    M Sepe
    V R Villella
    F Tolino
    M Vivo
    V Calabrò
    G La Mantia
    Oncogene, 2007, 26 : 5154 - 5162
  • [40] TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation
    Pollice, A.
    Sepe, M.
    Villella, V. R.
    Tolino, F.
    Vivo, M.
    Calabro, V.
    La Mantia, G.
    ONCOGENE, 2007, 26 (35) : 5154 - 5162